The study for clinical usefulness of the cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer
Not Applicable
- Conditions
- lung cancer, breast cancer
- Registration Number
- JPRN-UMIN000005553
- Lead Sponsor
- Osaka prefectural Medical Center for Respiratory and Allergic Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1:Patient who judged that research representative or allotment researcher is improper 2:Bisphosphonate administering patient 3:Metabolic bone disease patient 4:Kidney function deterioration patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1:Severrity of symptoms of bone metastasis in bone scintigraphy and comparative study of NTx 2-1:Utility examination of NTX in monitor of therapeutic gain after bone metastasis is diagnosed and bone metastasis progress level 2-2:Utility of bone metastasis index
- Secondary Outcome Measures
Name Time Method